ENZO BIOCHEM INC

NYSE: ENZ (Enzo Biochem, Inc.)

Last update: 3 days ago, 1:02AM

2.36

0.01 (0.43%)

Previous Close 2.35
Open 2.35
Volume 111,969
Avg. Volume (3M) 879,181
Market Cap 117,358,312
Price / Sales 0.870
Price / Book 0.550
52 Weeks Range
1.00 (-57%) — 2.75 (16%)
Earnings Date 7 Jun 2023 - 12 Jun 2023
TTM Dividend Yield 26.21%
Profit Margin -73.25%
Operating Margin (TTM) -21.84%
Diluted EPS (TTM) -0.140
Quarterly Revenue Growth (YOY) -14.30%
Total Debt/Equity (MRQ) 6.73%
Current Ratio (MRQ) 3.04
Operating Cash Flow (TTM) -14.96 M
Levered Free Cash Flow (TTM) -18.95 M
Return on Assets (TTM) -7.46%
Return on Equity (TTM) -12.94%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Mixed
Diagnostics & Research (Global) Mixed Mixed
Stock Enzo Biochem, Inc. - -

AIStockmoo Score

-0.6
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -5.0
Technical Moving Averages 2.5
Technical Oscillators 0.0
Average -0.63

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ENZ 117 M 26.21% - 0.550
CRL 8 B - - 2.30
NVTA 321 M - - -
DHR 143 B 0.43% 38.60 2.89
TMO 174 B 0.26% 26.66 3.46
IQV 30 B - 25.90 5.27

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Value
% Held by Insiders 21.68%
% Held by Institutions 34.79%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria